CYP4F2 and cancer: CYP4F2-mediated 20-HETE production also triggered the production of interleukin-6 (IL-6) and TGF-β in cancer-associated fibroblasts (CAF) leading to immune evasion through the GPR75-STAT3-c-Jun axis.